This contract expires in 197 days (Oct 31, 2026).
FIRM FIXED PRICE
NOVARTIS PHARMACEUTICALS CORPORATION - PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML)
PIID: 36C24226N0216Solicitation ID: 36C24226Q0080
Signed Date: Oct 28, 2025Effective Date: Nov 1, 2025End Date: Closes in 197 days
Key Details
Description
PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML)
Contractor Information
Contractor: NOVARTIS PHARMACEUTICALS CORPORATION
UEI: NG61ZA8TADW3
CAGE Code: 04520
Location: EAST HANOVER, NJ
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.